Accelerating delivery of radiopharmaceutical trials

Published on: Oct 3, 2025

Radiopharmaceutical trials are gaining traction across oncology and other therapeutic areas—but challenges remain in delivery, access, and scalability. In this expert-led webinar, leaders in clinical research, regulatory strategy, operational execution, and patient advocacy explore how to de-risk and accelerate these programs through integrated planning and patient-focused design.

Hear directly from experts who have helped sponsors navigate the complexities of radiopharmaceutical development—from aligning nuclear medicine and oncology teams to designing inclusive trials and enabling access beyond academic hubs. Also featured is an oncology patient who participated in a radiopharmaceutical clinical trial, and he shares his journey and perspective on what drives patient engagement.

Watch the webinar

Return to Insights Center

Related Insights

Webinar

Challenges and best practices for developing Antibody-Drug Conjugates (ADCs)

Nov 12, 2024

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Blog

PD-1 inhibitors face scrutiny in esophageal cancer: Key takeaways for drug developers

Oct 4, 2024

Video

Part 2: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021

Video

Part 3: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021

Report

New Medicines, Novel Insights: Advancing Precision Oncology

May 14, 2024

Blog

Navigating the path to conditional approval: avoiding pitfalls in oncology drug applications

Feb 4, 2025

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Blog

Making cell and gene therapy more accessible in the treatment of solid tumors

Jun 4, 2024

Article

Australia: The Regulatory and Reimbursement Environment

Aug 28, 2023

Podcast

Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training

Jun 28, 2024

Podcast

Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials

Jun 28, 2024

Related Insights

Webinar

Challenges and best practices for developing Antibody-Drug Conjugates (ADCs)

Nov 12, 2024

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Blog

PD-1 inhibitors face scrutiny in esophageal cancer: Key takeaways for drug developers

Oct 4, 2024

Video

Part 2: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021

Video

Part 3: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021

Report

New Medicines, Novel Insights: Advancing Precision Oncology

May 14, 2024

Show more